IS Pharma (AIM:ISPH) share news, analysis and insight

IS Pharma (ISPH)

Market: AIM · Sector: Pharmaceuticals & Biotechnology

Company Insights

IS Pharma plc – placing at a premium gives confidence and we get a dividend as well

06/10/2010

The speciality pharmaceutical company has announced that it has raised £3.6m at 77p per share with Abingworth LLP, the strategic healthcare investor. The placing price surprisingly (at least in this market) represents a 9% premium to the closing price of…

More on IS Pharma

Company Insights

IS Pharma plc (AIM: ISPH), results marginally miss estimates but no big deal in the grand scheme

02/06/2010

The company, which provides specialist pharmaceuticals and equipment in core areas such as Oncology and Neurology saw revenue up 17% to £14.2m (2009: £12.2m).

Company Insights

IS Pharma (LON:ISPH)

30/04/2010

The specialist pharmaceuticals company launches more brands internationally

Company Insights

IS Pharma (LON:ISPH) snaps up the rights to Episil

04/03/2010

The international speciality pharmaceutical company is on the acquisition trail again!

Company Insights

IS Pharma : Variquel® approval and management continues to shine

23/11/2009

IS Pharma (LSE: ISPH), the international speciality pharmaceutical company, and a real star EIS qualifying issue from 2007 continues to deliver.

Smallcap Review

AIM for IHT Planning - 2

26/01/2009

A second batch of ‘AIM for IHT’ stock considerations from 2008 with H (H&T Group) to L (James Latham). Quite by accident another pawnbroker leads the way!

Smallcap Review

Small Cap review

12/09/2008

TOROTRAK The technology with this one may be great, but without any idea what the earnings potential is there is no way to gauge what premium (if any) the shares…

Smallcap Review

Small Cap Review

13/06/2008

Poor old Chamberlin! Its foundry has been around since 1890 and now it is subject to a ‘nuisance claim’ from a new housing development. No wonder British industry has a…

Search for AIM companies qualifying for relief from Inheritance Tax!

Use our unique screening tool to identify Inheritance Tax planning AIM companies

This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.

Investor’s Champion, making your money go further.

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

Updates

Get regular updates from Investor's Champion by email.

Get regular updates from Fundamental Asset Management by email

Subscription

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.

In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team

START FREE TRIAL

Credits

Get access to our premium content for as little as £3.20 per article.

Only pay for what you want to read
Easy credit payment system
Access to any of our excellent Premium content

GET CREDITS